CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

Once again Darnitsa became the NV magazine editorial board's partner in the preparation of the "Onwarding world "special issue

For the fifth year in a row, the pharmaceutical company Darnitsa acts as the main partner of the Ukrainian weekly socio-political magazine NV in the preparation of its special issue "Onwarding world", that the editorial board is processing together with the British The Economist edition. According to a well-established tradition, the special issue is released at the closing year end and contains forecasts of the known Ukrainian and foreign experts and thinkers.

"Therein we and our British colleagues gathered opinions of the states' heads and large companies' CEOs to discuss what the global economy, the  culture and technology world will be like next year. Among them is the president of Ukraine, whose column opens the Ukrainian part of this project," says NV editor-in-chief Vitaliy Sych in his foreword.

In addition to President Volodymyr Zelensky, representatives of big business, sociologists, economists, officials, and scientists shared their thoughts on the future of Ukraine and the world in the Ukrainian part of this project. Among those authors are Dmytro Shymkiv, the Darnitsa Group Board of Directors Chairman, Arup Banerjee, the World Bank's Regional Director for Eastern Europe, Ugur Sahin and Ozlem Tureci, founders of BioNTech, Mykhailo Fedorov, the Minister of Digital Transformation of Ukraine, and historian Yaroslav Hrytsak.

Thus, the Ukrainian president stressed that the future life of Ukraine depends on the success of 2022, and these successes are impossible without vaccination. According to Mykhailo Fedorov, Ukraine can become the largest IT hub in Eastern Europe, and Dmytro Shymkiv is confident that innovations will give bread to the next generations of Ukrainians.

From year to year, Darnitsa joins the project to acknowledge Ukrainians with the opinions of leading Western experts in economics, politics and other fields. This knowledge obtained, our citizens get the opportunity to reflect on an equal footing as domestic leaders of public opinion about the State's future and on what impact on our future shall  produce the decisions made today already.

Among other large scale media projects of Darnitsa the website** shall be mentioned. It contains up-to-date information about the so-called postcovid syndrome (the presence of coronavirus disease symptoms even several months after recovery) from leading experts  all over the world, data, confirmed by the evidence-based medicine. That constantly updated information is available to every internet user.

Darnitsa also initiated the project "Znebol", in which, together with women leaders of public opinion, the Company talks in the media about the problems of various types  pain, including in women, and fights stereotypes on this topic.


The  pharmaceutical company "PRJSC "Darnitsa" was founded in 1930. Since 1998, Darnitsa become the leader in Ukraine in terms of drug production in kind. Strategic areas of the Company portfolio development include cardiology, neurology, and pain management. During 2015-2020, Darnitsa launched 50 pharmaceutical brands on the market.

** The information on this site is exceptional fo general reference and cannot be used for self-diagnosis or self-treatment.